| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/KI.1996.491 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ki.1996.491 |
| P698 | PubMed publication ID | 8914042 |
| P2093 | author name string | A Luchner | |
| J C Burnett | |||
| T P Dousa | |||
| T Supaporn | |||
| D M Heublein | |||
| S M Sandberg | |||
| C M Wei | |||
| D D Borgeson | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| Natriuretic peptide system in human heart failure | Q28261612 | ||
| Concentrating defect in the adrenalectomized rat. Abnormal vasopressin-sensitive cyclic adenosine monophosphate metabolism in the papillary collecting duct | Q33822324 | ||
| Role of endogenous atrial natriuretic factor in acute congestive heart failure | Q34581546 | ||
| A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction | Q35552979 | ||
| Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus | Q37023926 | ||
| Modulation of cyclic nucleotides in islated rat glomeruli: role of histamine, carbamylcholine, parathyroid hormone, and angiotensin-II. | Q37034302 | ||
| Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP. | Q37690399 | ||
| The biochemical pharmacology of atrial peptides | Q38253632 | ||
| Action of serotonin (5-hydroxytryptamine) on cyclic nucleotides in glomeruli of rat renal cortex | Q40254672 | ||
| Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion | Q40919655 | ||
| ADH resistance of LLC-pk1 cells caused by overexpression of cAMP-phosphodiesterase type-IV. | Q41549700 | ||
| Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through cGMP | Q41555372 | ||
| Isozymes of cyclic-3',5'-nucleotide phosphodiesterases in renal epithelial LLC-PK1 cells | Q41650216 | ||
| High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus | Q44578831 | ||
| Different effects of ANP and nitroprusside on cyclic GMP extrusion of isolated aorta | Q45177577 | ||
| Pathophysiological role of changing atrial size and pressure in modulation of atrial natriuretic factor during evolving experimental heart failure | Q47445197 | ||
| Second messenger changes of atrial natriuretic factor and brain natriuretic peptide in kidneys of cardiomyopathic hamsters | Q48221167 | ||
| Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide | Q48682176 | ||
| Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. | Q53790656 | ||
| Decreased atrial natriuretic factor receptors and impaired cGMP generation in glomeruli from the cardiomyopathic hamster. | Q54357501 | ||
| Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition. | Q54367434 | ||
| Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation | Q67703444 | ||
| Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD) | Q68430599 | ||
| Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects | Q68602093 | ||
| Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates | Q69836010 | ||
| Atrial natriuretic peptide elevation in congestive heart failure in the human | Q69987259 | ||
| Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure | Q70014821 | ||
| Stimulation of cyclic GMP synthesis in human cultured glomerular cells by atrial natriuretic peptide | Q70144109 | ||
| The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog | Q70334836 | ||
| Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction | Q70743359 | ||
| Endothelin in human congestive heart failure | Q72344120 | ||
| Increased nitric oxide production in heart failure | Q72687252 | ||
| Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV | Q72735569 | ||
| Presence of C-type natriuretic peptide in human kidney and urine | Q72898091 | ||
| Inhibition of cyclic GMP phosphodiesterases augments renal responses to atrial natriuretic factor in congestive heart failure | Q74011048 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| congestive heart failure | Q19000661 | ||
| P304 | page(s) | 1718-1725 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Blunted cGMP response to agonists and enhanced glomerular cyclic 3',5'-nucleotide phosphodiesterase activities in experimental congestive heart failure | |
| P478 | volume | 50 |
| Q74315515 | Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure |
| Q26745608 | Altered Nitric Oxide System in Cardiovascular and Renal Diseases |
| Q37108057 | Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction |
| Q37257355 | B-type natriuretic peptide: beyond a diagnostic |
| Q37256856 | Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide |
| Q33573360 | Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent |
| Q36860608 | Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancing in vivo and ex vivo actions |
| Q43777080 | Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure |
| Q28564609 | Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells |
| Q37209666 | Endothelial permeability in vitro and in vivo: protective actions of ANP and omapatrilat in experimental atherosclerosis |
| Q39258545 | Evolving treatment strategies for management of cardiorenal syndrome |
| Q33792340 | Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte |
| Q28567704 | Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat |
| Q61576278 | Increased activity of guanosine 3′-5′-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites |
| Q42077578 | Increased peripheral resistance in heart failure: new evidence suggests an alteration in vascular smooth muscle function |
| Q37395026 | Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. |
| Q37108093 | Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure |
| Q37329891 | Modulation of cGMP in heart failure: a new therapeutic paradigm |
| Q34027488 | Natriuretic peptides in the pathophysiology of congestive heart failure |
| Q38594785 | New medical therapies for heart failure |
| Q34622165 | Peripheral limitations of maximal aerobic capacity in patients with chronic heart failure |
| Q92009329 | Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure |
| Q37091016 | The cyclic guanosine monophosphate/B-type natriuretic peptide ratio and mortality in advanced heart failure |
| Q38973055 | The enigma of continual plasma volume expansion in pregnancy: critical role of the renin-angiotensin-aldosterone system |
Search more.